Know Cancer

or
forgot password

Colonoscopy Screening Using a Novel Slim Colonoscope - a Randomized Controlled Trial


Phase 3
54 Years
64 Years
Not Enrolling
Both
Colorectal Cancer, Adenomas

Thank you

Trial Information

Colonoscopy Screening Using a Novel Slim Colonoscope - a Randomized Controlled Trial


Inclusion Criteria:



- Persons included in the NordICC trial are eligible for inclusion

- For information about the NordICC trial see clinicaltrials.gov NCT00883792

Exclusion Criteria:

- Pregnancy

- Persons younger than 18 years

- Persons unable to comprehend the information given

- not possible to start the examination without prior administration of
sedation/analgesics

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Diagnostic

Outcome Measure:

Patients┬┤ evaluation of pain and discomfort

Outcome Description:

Analysis of validated feed-back questionnaires to be filled in on the day after the proceudre by the trial participants.

Outcome Time Frame:

24 hours

Safety Issue:

No

Principal Investigator

Michael Bretthauer, MD, Ph.d.

Investigator Role:

Study Chair

Investigator Affiliation:

Oslo University Hospital

Authority:

Norway: Regional Ethics Commitee

Study ID:

PCF-Y0014-L

NCT ID:

NCT01370928

Start Date:

March 2011

Completion Date:

August 2011

Related Keywords:

  • Colorectal Cancer
  • Adenomas
  • Colonoscopy performance
  • Pain
  • Discomfort
  • Screening
  • Colorectal cancer
  • Colorectal cancer screening, diagnostics of adenomas
  • Adenoma
  • Colorectal Neoplasms

Name

Location